Morphine enhances Tat-induced activation in murine microglia

References

• Adler H, Peterhans E, Jungi TW. Generation and functional characterization of bovine bone marrow-derived macrophages. Vet Immunol Immunopathol 1994; 41: 211–227
   PubMed Web of Science ®Google Scholar
• Alliot F, Godin I, Pessac B. Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain. Brain Res Dev Brain Res 1999; 117: 145–152
   Google Scholar
• Bell JE, Donaldson YK, Lowrie S, McKenzie CA, Elton RA, Chiswick A, Brettle RP, Ironside JW, Simmonds P. Influence of risk group and zidovudine therapy on the development of HIV encephalitis and cognitive impairment in AIDS patients. AIDS 1996; 10: 493–499
   PubMed Web of Science ®Google Scholar
• Bokhari SM, Kim KJ, Pinson DM, Slusser J, Yeh HW, Parmely MJ. NK cells and gamma interferon coordinate the formation and function of hepatic granulomas in mice infected with the Francisella tularensis live vaccine strain. Infect Immun 2008; 76: 1379–1389
   PubMed Web of Science ®Google Scholar
• Bonwetsch R, Croul S, Richardson MW, Lorenzana C, Del Valle L, Sverstiuk AE, Amini S, Morgello S, Khalili K, Rappaport J. Role of HIV-1 Tat and CC chemokine MIP-1alpha in the pathogenesis of HIV associated central nervous system disorders. J NeuroVirol 1999; 5: 685–694
   Web of Science ®Google Scholar
• Budka H. The definition of HIV-specific neuropathology. Acta Pathol Jpn 1991; 41: 182–191
   PubMedGoogle Scholar
• Chao CC, Hu S, Shark KB, Sheng WS, Gekker G, Peterson PK. Activation of mu opioid receptors inhibits microglial cell chemotaxis. J Pharmacol Exp Ther 1997; 281: 998–1004
   Google Scholar
• Chen AC, LaForge KS, Ho A, McHugh PF, Kellogg S, Bell K, Schluger RP, Leal SM, Kreek MJ. Potentially functional polymorphism in the promoter region of prodynorphin gene may be associated with protection against cocaine dependence or abuse. Am J Med Genet 2002; 114: 429–435
   PubMed Web of Science ®Google Scholar
• D'Aversa TG, Weidenheim KM, Berman JW. CD40-CD40L interactions induce chemokine expression by human microglia: implications for human immunodeficiency virus encephalitis and multiple sclerosis. Am J Pathol 2002; 160: 559–567
   PubMed Web of Science ®Google Scholar
• D'Aversa TG, Yu KO, Berman JW. Expression of chemokines by human fetal microglia after treatment with the human immunodeficiency virus type 1 protein Tat. J NeuroVirol 2004; 10: 86–97
   Google Scholar
• Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, Littman DR, Dustin ML, Gan WB. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 2005; 8: 752–758
   PubMed Web of Science ®Google Scholar
• de Goer de Herve MG, Delfraissy JF, Taoufik Y. Following direct CD40 activation, human primary microglial cells produce IL-12 p40 but not bioactive IL-12 p70. Cytokine 2001; 14: 88–96
   Google Scholar
• Donahoe RM, Vlahov D. Opiates as potential cofactors in progression of HIV-1 infections to AIDS. J Neuroimmunol 1998; 83: 77–87
   PubMed Web of Science ®Google Scholar
• Fetler L, Amigorena S. Neuroscience. Brain under surveillance: the microglia patrol. Science 2005; 309: 392–393
   PubMedGoogle Scholar
• Fischer-Smith T, Rappaport J. Evolving paradigms in the pathogenesis of HIV-1-associated dementia. Expert Rev Mol Med 2005; 7: 1–26
   PubMedGoogle Scholar
• Garden GA, Guo W, Jayadev S, Tun C, Balcaitis S, Choi J, Montine TJ, Moller T, Morrison RS. HIV associated neurodegeneration requires p53 in neurons and microglia. FASEB J 2004; 18: 1141–1143
   PubMed Web of Science ®Google Scholar
• Ghafouri M, Amini S, Khalili K, Sawaya BE. HIV-1 associated dementia: symptoms and causes. Retrovirology 2006; 3: 28
   PubMed Web of Science ®Google Scholar
• Glass JD, Wesselingh SL, Selnes OA, McArthur JC. Clinical-neuropathologic correlation in HIV-associated dementia. Neurology 1993; 43: 2230–2237
   PubMedGoogle Scholar
• Gonzalez-Scarano F, Baltuch G. Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci 1999; 22: 219–240
   PubMed Web of Science ®Google Scholar
• Grimaldi LM, Martino GV, Franciotta DM, Brustia R, Castagna A, Pristera R, Lazzarin A. Elevated alpha-tumor necrosis factor levels in spinal fluid from HIV-1-infected patients with central nervous system involvement. Ann Neurol 1991; 29: 21–25
   PubMed Web of Science ®Google Scholar
• Hanisch UK. Microglia as a source and target of cytokines. Glia 2002; 40: 140–155
   PubMed Web of Science ®Google Scholar
• Kong LY, Wilson BC, McMillian MK, Bing G, Hudson PM, Hong JS. The effects of the HIV-1 envelope protein gp120 on the production of nitric oxide and proinflammatory cytokines in mixed glial cell cultures. Cell Immunol 1996; 172: 77–83
   PubMed Web of Science ®Google Scholar
• Kruman II, Nath A, Mattson MP. HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress. Exp Neurol 1998; 154: 276–288
   PubMed Web of Science ®Google Scholar
• Ling EA, Wong WC. The origin and nature of ramified and amoeboid microglia: a historical review and current concepts. Glia 1993; 7: 9–18
   PubMed Web of Science ®Google Scholar
• Liu B, Du L, Kong LY, Hudson PM, Wilson BC, Chang RC, Abel HH, Hong JS. Reduction by naloxone of lipopolysaccharide-induced neurotoxicity in mouse cortical neuron-glia co-cultures. Neuroscience 2000; 97: 749–756
   Google Scholar
• Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, Befort K, Dierich A, Le Meur M, Dolle P, Tzavara E, Hanoune J, Roques BP, Kieffer BL. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 1996; 383: 819–823
   PubMed Web of Science ®Google Scholar
• Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005; 308: 1314–1318
   PubMed Web of Science ®Google Scholar
• Pessac B, Godin I, Alliot F. 2001. [Microglia: origin and development.]. Bull Acad Natl Med, 185: 337–346; discussion 346–347.
   Google Scholar
• Pottler M, Zierler S, Kerschbaum HH. An artificial three-dimensional matrix promotes ramification in the microglial cell-line, BV-2. Neurosci Lett 2006; 410: 137–140
   Google Scholar
• Rock, RB, Gekker, G, Hu, S, Sheng, WS, Cheeran, M, Lokensgard, JR, Peterson, PK. 2004. Role of microglia in central nervous system infections. Clin Microbiol Rev, 17: 942–964; table of contents.
   PubMed Web of Science ®Google Scholar
• Ruzicka BB, Fox CA, Thompson RC, Meng F, Watson SJ, Akil H. Primary astroglial cultures derived from several rat brain regions differentially express mu, delta and kappa opioid receptor mRNA. Brain Res Mol Brain Res 1995; 34: 209–220
   PubMedGoogle Scholar
• Schwarz M, Nordt T, Bode C, Peter K. The GP IIb/IIIa inhibitor abciximab (c7E3) inhibits the binding of various ligands to the leukocyte integrin Mac-1 (CD11b/CD18, alphaMbeta2). Thromb Res 2002; 107: 121–128
   Google Scholar
• Steele AD, Henderson EE, Rogers TJ. Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication. Virology 2003; 309: 99–107
   PubMed Web of Science ®Google Scholar
• Stiene-Martin A, Zhou R, Hauser KF. Regional, developmental, and cell cycle-dependent differences in mu, delta, and kappa-opioid receptor expression among cultured mouse astrocytes. Glia 1998; 22: 249–259
   PubMed Web of Science ®Google Scholar
• UNAIDS. (2006). report on the global aids epidemic. Geneva: UNAIDS; 2006.
   Google Scholar